Literature DB >> 23198012

Warfarin-induced Venous Limb Gangrene.

Sarah Grim Hostetler1, Jennifer Sopkovich, Steven Dean, Matthew Zirwas.   

Abstract

Warfarin is a commonly used anticoagulant that has been associated with several significant cutaneous side effects, most notably warfarin-induced skin necrosis. A lesser known adverse reaction to warfarin is warfarin-induced venous limb gangrene. Both cutaneous adverse effects share the same pathophysiology, but are clinically quite different. The majority of cases of warfarin-induced venous limb gangrene has been in patients with cancer or heparin-induced thrombocytopenia. However, other hypercoagulable disease states, such as the antiphospholipid antibody syndrome, can be associated with venous limb gangrene. In order to increase recognition of this important condition, the authors report a case of warfarin-induced venous limb gangrene in a patient with presumed antiphospholipid antibody syndrome and review the literature on warfarin-induced venous limb gangrene.

Entities:  

Year:  2012        PMID: 23198012      PMCID: PMC3509881     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  18 in total

Review 1.  The antiphospholipid syndrome.

Authors:  Jerrold S Levine; D Ware Branch; Joyce Rauch
Journal:  N Engl J Med       Date:  2002-03-07       Impact factor: 91.245

Review 2.  Transition to an oral anticoagulant in patients with heparin-induced thrombocytopenia.

Authors:  John R Bartholomew
Journal:  Chest       Date:  2005-02       Impact factor: 9.410

Review 3.  Heparin-induced thrombocytopenia: IgG-mediated platelet activation, platelet microparticle generation, and altered procoagulant/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-induced thrombocytopenia.

Authors:  T E Warkentin
Journal:  Transfus Med Rev       Date:  1996-10

4.  Real world experience with antiphospholipid antibody tests: how stable are results over time?

Authors:  D Erkan; W J M Derksen; V Kaplan; L Sammaritano; S S Pierangeli; R Roubey; M D Lockshin
Journal:  Ann Rheum Dis       Date:  2005-02-24       Impact factor: 19.103

Review 5.  Multicentric warfarin-induced skin necrosis complicating heparin-induced thrombocytopenia.

Authors:  T E Warkentin; W M Sikov; D P Lillicrap
Journal:  Am J Hematol       Date:  1999-09       Impact factor: 10.047

6.  Venous limb gangrene during warfarin treatment of cancer-associated deep venous thrombosis.

Authors:  T E Warkentin
Journal:  Ann Intern Med       Date:  2001-10-16       Impact factor: 25.391

Review 7.  Evolving management strategies for heparin-induced thrombocytopenia.

Authors:  Lawrence Rice
Journal:  Semin Hematol       Date:  2005-07       Impact factor: 3.851

8.  Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin-induced thrombocytopenia.

Authors:  Maureen A Smythe; Theodore E Warkentin; Jennifer L Stephens; Dana Zakalik; Joan C Mattson
Journal:  Am J Hematol       Date:  2002-09       Impact factor: 10.047

9.  Warfarin-associated multiple digital necrosis complicating heparin-induced thrombocytopenia and Raynaud's phenomenon after aortic valve replacement for adenocarcinoma-associated thrombotic endocarditis.

Authors:  Theodore E Warkentin; Richard P Whitlock; Kevin H T Teoh
Journal:  Am J Hematol       Date:  2004-01       Impact factor: 10.047

10.  Warfarin-induced limb gangrene in the setting of lung adenocarcinoma.

Authors:  Liviu Klein; Angel Galvez; Oana Klein; Juan Chediak
Journal:  Am J Hematol       Date:  2004-06       Impact factor: 10.047

View more
  3 in total

1.  Warfarin associated venous limb gangrene in cancer-related DVT (case report).

Authors:  Vladimir Cojocari; Dumitru Casian; Eugen Gutu
Journal:  Int J Surg Case Rep       Date:  2017-01-23

Review 2.  Pigmented purpura and cutaneous vascular occlusion syndromes.

Authors:  Ana Cecilia Lamadrid-Zertuche; Verónica Garza-Rodríguez; Jorge de Jesús Ocampo-Candiani
Journal:  An Bras Dermatol       Date:  2018-06       Impact factor: 1.896

3.  Ovarian malignancy unmasked by venous gangrene in a patient on warfarin therapy: a case report.

Authors:  Amgad Said; Justin Keasberry
Journal:  J Med Case Rep       Date:  2016-06-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.